Warning message

The following search keys are too short or too common and were therefore ignored: "si".
  1. News | 2022.07.09

    Conversation: capacity building to prepare for the future

    Institut Pasteur Senior Executive Scientific Vice-President Christophe d'Enfert provides a brief, cross-disciplinary overview of 2021 covering capacity building, enhanced partnerships and future technologies.

  2. News | 2022.07.08

    Conversation: 2021, a pivotal year for the Institut Pasteur's future

    Institut Pasteur Board of Governors Chairman Christian Vigouroux and President Prof. Sir Stewart Cole share their thoughts on the year's highlights. 2021 was a pivotal year poised between maintaining financial stability and supporting scientific projects.

  3. News | 2022.07.11

    A snapshot of 2021's highlights

    Following the release of the 2021 edition of the Institut Pasteur's Annual Report, here are some of the year's highlights. Twelve eventful months interspersed with highlightsmajor scientific breakthroughs and key events for the institute in all fields including COVID-19, cancer, neuroscience, genetics, vaccinology and antibiotic resistance.

  4. News | 2021.10.18

    "COVID-19, cancers and antibiotic resistance: meeting the researchers of the Institut Pasteur": programme available for replay

    For the opening of the Pasteurdon 2021, scientists from the Institut Pasteur took part in a digital programme looking at some of the major current issues in medical research, "COVID-19, cancers and antibiotic resistance: meeting Institut Pasteur researchers", in partnership with Figaro Partner. Watch online (in French).

  5. News | 2021.10.18

    The replay of the conference "COVID-19, Advances and Remaining Challenges" is available

    For three days, worldwide specialists shared their views about the pandemic during a congress hosted by the Institut Pasteur. Their contributions are to be found online.

  6. Report | 2024.05.03

    The lowdown on meningitis, a public health challenge

    On April 26, 2024, the World Health Organization held a high-level meeting at the Institut Pasteur to highlight the importance of tackling meningitis, a disease that comes in multiple, often severe forms, some of which can kill in the space of hours. It is crucial that we improve our knowledge of meningitis. What are the symptoms, and how can it be prevented? Vaccination is the solution, both to...

  7. Report | 2024.06.17

    Vector-borne diseases: Mosquitoes, ticks, biting flies... how far will they go?

    Vector-borne diseases: Mosquitoes, ticks, biting flies... how far will they go?

  8. News | 2024.05.06

    Risk of listeriosis associated with vegan cheeses

    An analysis coordinated by the National Reference Center for Listeria, Santé publique France and the French General Directorate for Food, in collaboration with Belgian, German and Dutch experts, has concluded that a listeriosis outbreak that occurred in Europe was linked with the consumption of vegan, plant-based cheeses. It found that the proliferation rate of Listeria monocytogenes is actually...

  9. Document de presse | 2024.05.17

    The Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Ceará

    Inaugurated this Friday (5/17), the Pasteur Fiocruz Center on Immunology and Immunotherapy, located in Fiocruz-Ceará, brings together scientists from the Institut Pasteur and Fiocruz, two Pasteur Network members, to develop an integrative approach to immunotherapies applied to both infectious and non-communicable diseases. This scientific cooperation aims to accelerate research in immunology and...

  10. Événement | 2024.06.25

    Pasteur Innov’ Day: Fundamentally Applied ! 2nd edition – June 25, 2024

    After a first successful edition in 2022, Pasteur Innov’ Day will be back at the Institut Pasteur Conference Center on June 25, 2024 from 2 p.m to 6 p.m (followed by a drinks reception). This year’s goal is the same as last year : to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector (from startups and mid-caps to major...

Pages

Back to top